Table 3.

Sensitivity analysis of this study

Outcomes		All Studies			Good Quality Studies
	N	Patients	RR (95%CI)	P	N	Patients	RR (95%CI)	P
Tumor response	27	1849	1.19[1.07,1.32]	0.001	9	640	1.16[0.98,1.38]	0.08
KPS	20	1336	1.57[1.45,1.70]	<0.00001	4	296	1.45[1.25,1.68]	<0.00001
WBC	20	1463	0.37[0.29,0.47]	<0.00001	7	510	0.32[0.21,0.48]	<0.00001
PLT	18	1335	0.33[0.21,0.52]	<0.00001	6	450	0.21[0.09,0.50]	0.0005
HB	15	1161	0.44[0.30,0.66]	<0.001	5	362	0.37[0.19,0.72]	0.003
Nausea and Vomiting	14	1031	0.32[0.22,0.47]	<0.00001	5	389	0.41[0.22,0.77]	0.006

Abbreviations: KPS, Karnofsky Performance status; WBC, white blood cell; PLT, platelet; HB, hemoglobin; N, the number of trials.